ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Graft acceptance"

  • 2016 American Transplant Congress

    Distinct Phenotype and Function of Plasmacytoid Dendritic Cells from Kidney Allografts in Tolerant Recipients.

    N. Oh,1,2 C. Yang,1,2,3 M. Tonsho,1,2 D. Ndishabandi,1,2,3 P. Russell,1,2 R. Colvin,1,3 J. Madsen,1,2 A. Alessandrini.1,2

    1Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA; 2Department of Surgery, Massachusetts General Hospital, Boston, MA; 3Department of Pathology, Massachusetts General Hospital, Boston, MA.

    BACKGROUND: Cellular infiltrates in kidney allografts may be relevant to the induction or maintenance of regulatory tolerance. Here we examined the phenotype, anatomical distribution and…
  • 2016 American Transplant Congress

    Tolerogenic Interactions Between Host CD8+Myeloid Dendritic Cells and Natural Killer T Cells Are Required for Acceptance of Combined Organ and Bone Marrow Transplants After TLI Conditioning.

    D. Hongo Apum,1 X. Zhang,2 E. Engleman,2 S. Strober.1

    1Medicine - Division of Immunology & Rheumatology, Stanford University, Stanford, CA; 2Medicine - Department of Pathology, Stanford University, Stanford, CA.

    Combined transplantation of solid organs and bone marrow or hematopoietic progenitor cells has resulted in successful achievement of tolerance in both laboratory animals and in…
  • 2015 American Transplant Congress

    Structure/Function Insights Into Treg Biology: Hdac11 Is a Foxp3 Deacetylase Whose Targeting Promotes and Stabilizes Foxp3 Expression and Leads to Long-Term Allograft Survival

    J. Huang,1 L. Wang,1 T. Bhatti,1 A. Samanta,1 S. Dahiya,1 R. Han,1 J. Bergman,2 A. Kozikowski,2 W. Hancock.1

    1CHOP & UPenn, Philadelphia; 2Uni of Illinois at Chicago, Chicago.

    Aim: There are huge scientific, economic and practical advantages in developing pharmacologic approaches to enhance Foxp3+ Treg function in allograft recipients versus simply injecting enormous…
  • 2015 American Transplant Congress

    IL-21 Regulates Creation of Tertiary Lymphoid Organs in Chronic Allograft Rejection

    C. Baum,1 M. Khattar,2 P. Schroder,1 W. Chen,3 S. Stepkowski.1

    1Medical Microbiology and Immunology, University of Toledo College of Medicine, Toledo, OH; 2Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA; 3Transplant Immunology Research Program, Houston Methodist Research Institute, Houston, TX.

    BACKGROUND: IL-21 is a cytokine expressed almost exclusively by cells of the adaptive immune system. This makes it an attractive target for reducing chronic allograft…
  • 2015 American Transplant Congress

    A Prospective Comparison of the Completeness of Donor Kidney Biopsies

    S. Ahmad,1 E. Siskind,1 C. Drachenberg,2 J. Bromberg,1 S. Niederhaus.1

    1Transplantation, University of Maryland, Baltimore; 2Pathology, University of Maryland, Baltimore.

    Background: The use of expanded criteria kidneys has plateaued, possibly due to inadequate pathologic evaluation or lack of a universal grading system. We examined pre-transplant…
  • 2015 American Transplant Congress

    "In-House" Controlled Oxygenated Rewarming After Initial Static Cold Storage: First Clinical Application in Marginal Donor Livers

    D. Hoyer,1 Z. Mathé,1 A. Gallinat,1 A. Canbay,2 J. Treckmann,1 U. Rauen,3 A. Paul,1 T. Minor.4

    1General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany; 2Gastroenterology and Hepatology, University Hospital Essen, Essen, Germany; 3Institute of Physiological Chemistry, University Hospital Essen, Essen, Germany; 4Surgical Research Division, University Hospital Bonn, Bonn, Germany.

    IntroductionControlled oxygenated rewarming of cold stored livers by machine perfusion demonstrated a strong protective effect in preclinical studies. Here we report on the first clinical…
  • 2015 American Transplant Congress

    Poor Renal Function and Increased Mortality in Elderly Recipients of Deceased Donor Kidneys from Elderly Donors

    S. Berger,1 H. Peters-Sengers,2 M. Heemskerk,3 F. Bemelman,2 J. Homan van der Heide.2

    1Department of Internal Medicine, University Medical Center Groningen, Groningen, Netherlands; 2Department of Nephrology, Academic Medical Center, Amsterdam, Netherlands; 3Dutch Transplant Foundation, Leiden, Netherlands.

    Background: Within the Eurotransplant Senior Program kidneys form donors older than 65 both after cardiac death (DCD) or brain death (DBD) are allocated to recipients…
  • 2015 American Transplant Congress

    Donor Specific Tolerance Can Be Induced by Donor Bone Marrow Transfer With Activation of Invariant Naturel Killer T Cells

    S. Miyairi,1 T. Hirai,1 R. Shibahara,1 K. Omoto,1 S. Nunoda,2 K. Yamazaki,2 Y. Ishii,3 K. Tanabe.1

    1Urology, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan; 2Cardiovascular Surgery, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan; 3Laboratory of Vaccine Design, RIKEN IMS-RCAI, Yokohama, Japan.

    It has been reported that liposomal formulation of a-galactosylceramide(lipo-aGC) could induce antigen specific regulatory T cells (Treg) in vivo when administered with particular antigens. We…
  • 2015 American Transplant Congress

    Human Hematopoietic Chimeric Cells as a Novel Approach for Tolerance Induction After Transplantation

    E. Bryndza Tfaily,1 J. Cwykiel,1 K. Dastych,2 A. Sklodowska,1 M. Siemionow.1

    1Orthopaedics, University of Illinois at Chicago, Chicago, IL; 2Pathology, University of Illinois at Chicago, Chicago, IL.

    Background: Cellular therapies represent a new promising approach for transplant tolerance induction. One of the methods for immune response modulation in solid organ and vascularized…
  • 2015 American Transplant Congress

    Is the Pulsatile Kidney Preservation Machine a Vaulable Tool in Evaluating Kidney Suitability from Older Donors After Brain Death?

    D. Paredes Zapata,1 A. Ruiz Arranz,1 C. Rodriguez Villar,1 L. Peri Cussi,2 A. Alcaraz Asensio,2 R. Adalia Bartolome,1 F. Oppenheimer Salinas.3

    1Donation and Transplant Coordination Section, Hospital Clinic, University of Barcelona, Barcelona, Spain; 2Urology Department, Hospital Clinic, University of Barcelona, Barcelona, Spain; 3Renal Transplant Unit, Hospital Clinic, Barcelona, Spain.

    Introduction: Donors after Brain Death (DBD) older than 60 years old, have become 46.8% of our donor activity, with higher Discard Rate (DR). Assessment of…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences